Europe Must Seize Opportunity For Change
Five Key Issues For EU Pharma Strategy Cited By Medicines For Europe
The EU’s upcoming pharma strategy offers an important opportunity for change, according to Medicines for Europe. The off-patent industry body has set out five key issues that should be priorities for the EU Commission.
